ABT-751 in relapsed childhood acute lymphoblastic leukemia

J Pediatr Hematol Oncol. 2012 Oct;34(7):583-4. doi: 10.1097/MPH.0b013e3182532446.

Paul S Gaynon, Theresa M Harned, Therapeutic Advances in Childhood Leukemia/Lymphoma Consortium

PMID: 22584778 DOI: 10.1097/MPH.0b013e3182532446

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-13270

ABT-751

99.40%, Sulfonamides Antimitotic Compounds/Tubulin Binders Agent

Microtubule/Tubulin; Autophagy; Apoptosis

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us